Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$617K Sell
5,129
-17
-0.3% -$1.96K 0.03% 265
2025
Q4
$542K Buy
5,146
+572
+13% +$53.7K 0.02% 287
2025
Q3
$384K Buy
4,574
+408
+10% +$33.6K 0.02% 201
2025
Q2
$330K Sell
4,166
-1,077
-21% -$85.6K 0.02% 189
2025
Q1
$471K Sell
5,243
-263
-5% -$24.6K 0.03% 157
2024
Q4
$548K Buy
5,506
+462
+9% +$47.6K 0.04% 142
2024
Q3
$573K Buy
5,044
+970
+24% +$115K 0.04% 134
2024
Q2
$504K Sell
4,074
-278
-6% -$35.8K 0.04% 113
2024
Q1
$574K Buy
4,352
+273
+7% +$33.6K 0.04% 119
2023
Q4
$445K Buy
4,079
+629
+18% +$65.3K 0.04% 123
2023
Q3
$355K Sell
3,450
-201
-6% -$21.7K 0.03% 126
2023
Q2
$421K Sell
3,651
-899
-20% -$102K 0.03% 116
2023
Q1
$484K Buy
+4,550
New +$491K 0.05% 109

Other funds holding MRK

BIP Wealth's MRK Position: Q1 2026 in Review

BIP Wealth reduced its Merck (MRK) stake by 0.33% in Q1 2026, selling an estimated $1.96K and leaving 5,129 shares worth $617K. The position accounts for 0.03% of the portfolio, ranked #265.

BIP Wealth first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BIP Wealth held 5,129 shares of Merck worth $617K as of Q1 2026.
  • BIP Wealth sold 17 Merck shares in Q1 2026, an estimated $1.96K.
  • Merck made up 0.03% of BIP Wealth's portfolio in Q1 2026, its #265 holding.
  • BIP Wealth first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BIP Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.